About the Company

Lifespans is a medical device startup company founded by engineers and surgeons from MIT and the University of Hong Kong. We are on a mission to radically improve the way that bone fracture repair implants are designed for elderly patients with soft bones - 250 million people worldwide.

The first product from our R&D pipeline, the Lifespans Soft Hip Implant, is on currently undergoing US FDA/CE registration review as a  510(k) / Class II device.

Management Team and Advisors

Sloan Kulper, PhD     Chief Executive Officer
Sloan is an American engineer from MIT with deep ties to the Silicon Valley startup community. A serial entrepreneur and inventor with multiple international patents, he has built successful startups in four countries and raised millions of US dollars in grants and seed funding across multiple ventures. He has also served as an engineering consultant to several multinational medical device firms, including Fortune 500 firms Stryker and CR Bard. Sloan received a Bachelor of Science from the Massachusetts Institute of Technology (MIT), an MFA (industrial design) from the Rhode Island School of Design, and a PhD (biomedical engineering) from the Faculty of Medicine at the University of Hong Kong.

A/Prof. Christian Fang, FRCS     Chief Medical Officer
Chris is a surgeon and Clinical Assistant Professor in the HKU Department of Orthopaedics & Traumatology. Chris drives our mission to improve clinical outcomes and access to care through innovative technology, marketplace transparency, and rigorous ethical standards. A member of a large family of surgeons and physicians in Hong Kong, he also focuses on expanding the reach of the company and our networks among clinicians throughout Asia and worldwide. Educated at HKU (MBBS) and his fellowship received from the Royal College of Surgeons of Edinburgh (FRCSEd), he is the author of numerous papers and patents in the field of orthopaedic surgery.

Erica Ueda Boles, PhD     Chief Science Officer
Erica is a biomedical engineer who sets the R&D goals for Lifespans and is in charge of building and management of our engineering teams. She is also a co-founder of LifeCollection, shaping the strategy, vision, and culture of our marketplace venture. She obtained a B.S. from UCLA and M.S. from MIT in Mechanical Engineering. Erica worked at Abbot Vascular in Santa Clara and at the MGH Center for Systems Biology in Boston before obtaining her Ph.D. from KIT (Germany) in Chemistry & Biosciences, with a focus on lab-on-a-chip technologies.

Richard Holloway   Chief Marketing Officer
Richard is a medical device sales and marketing executive, previously of Stryker and DKSH - both leaders in the industry. Richard has managed sales teams in in the orthopaedics that grew sales volume from US$10M’s to US$100M’s within a several-year timeframe. With decades of experience selling orthopaedic implants worldwide, he works with our CEO to set our global sales and marketing strategy.


Prof. Frankie Leung, FRCS     Director, Clinical Strategy
Frankie is a senior surgeon and full Clinical Professor in the HKU Department of Orthopaedics & Traumatology, and an Assistant Dean of the medical faculty. A major contributor to international clinical standards in orthopaedic surgery, Frankie has a long relationship with the AO Foundation and multiple research collaborations with Synthes. He has led the education of numerous surgical trainees and is a globally-recognized thought leader in clinical practice and research, with numerous publications and patents. He was educated at HKU (MBBS) and his fellowship received from the Royal College of Surgeons of Edinburgh (FRCSEd).

LuW-bw.jpg

Prof. William Lu, PhD     Director, R&D Strategy
William is a biomedical engineer and chaired Professor in the HKU Department of Orthopaedics & Traumatology. In 1995 he founded the department’s Orthopaedic Research Centre, where he has served as director to the present day. Acknowledged as one of the top 1% of scholars in bioengineering from 2009-2013 by ISI’s essential science indicators, William has a strong track record of attracting seed funding, licensing, and acquisition from investors and major players in the medical device industry for his biomaterial and device inventions. William received his PhD from the University of Waterloo, Canada.

Adrian Chan photo bw cropped.jpg
Grace.png
 
Danielle Applestone.jpg
Paul Higham.jpg
Tom smaller.png
Ted Chang.jpg
Veiverne Yuen.jpg

Adrian Chan, CPA Australia & HKICPA    Chief Financial Officer
Adrian is an investment banker turned chief financial officer and has worked for a number of listed companies as well as private investment companies. This includes years of experience in corporate finance with previous dealings in the execution of financial advisory, initial public offering, merger and acquisitions, privatisation and other equity capital market transactions.

 

Grace Teng Zhang, PhD     Director of Clinical Affairs
Grace is a biomedical engineer from Sydney, Australia, who served as scientific officer (CRA) and coordinator of Spine mechanics, at Spine service of St George Hospital, Sydney from 2011-2017.  Grace worked closely with patients and clinicians to develop cutting edge therapeutic devices and treatment plans for leading medical device companies including Medtronic and NuVasive.  She has received multiple international and national awards including ABEC Best Speaker Award, iGlobal Entrepreneur Award,etc.  Grace completed BMedSc, MBiomedEng and PhD (Medicine) all from University of New South Wales.

Danielle Applestone, PhD     Advisor to the Board of Directors
Danielle is the CEO and co-founder of Other Machine Co., a leading manufacturer of workbench-scale CNC milling devices used by thousands of businesses and consumers worldwide. As CEO, she transitioned Other Machine Co from a subsidiary of the technology incubator OtherLab to a successful standalone company.  A prominent Silicon Valley entrepreneur, she is a regular speaker and panelist at technology and startup events and a sought-after advisor and board member to numerous new ventures. A graduate of MIT with a BsC in chemical engineering, she received a PhD in Materials Science from UT Austin. 


Paul Higham, PhD     Advisor to the Board of Directors
Paul is the former Director, Science at Stryker Orthopedics USA, where he oversaw the M&A process for numerous acquisition targets in the company - one of the top global manufacturers of devices for trauma implants, and a leader in innovation. An advisor to several early and mid-stage startups in the orthopaedics industry, Paul has been an active and regular participant in our strategic decision making process, helping us to structure the company for success since its inception. He holds a PhD in materials science from the University of Manchester.


Thomas Brewer, MBA    Advisor to the Board of Directors
Tom is an experienced executive from the orthopedics industry, serving in top management positions in Stryker and Orthofix. Additionally, he has successfully built numerous orthopedic implant ventures from the ground up, reaching profitability and acquisition. As general manager of implant startup Spine Next Corp, he led the company to acquisition by Abbott Labs in 2004.

 

Ted Chang, JD    Advisor to the Board of Directors
Ted is an attorney with extensive experience in private equity and venture capital investment in the USA and Asia. His background includes serving as general counsel and member of the board on numerous technology startups from early stage through M&A and IPO.

 

Veiverne Yuen, MS      Advisor to the Board of Directors
Veiverne is Managing Director of tryb, a leading fintech investment firm based in Singapore. He brings leadership experience from a career in world-class financial institutions (e.g. VP of the Singapore Government Investment Corporation) and technology firms (design engineer at Rolls-Royce aerospace).